SEOM clinical guidelines on venous thromboembolism (VTE) and cancer (2023)

1Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The Spanish Society of Medical Oncology (SEOM) last published clinical guidelines on venous thromboembolism (VTE) and cancer in 2019, with a partial update in 2020. In this new update to the guidelines, SEOM seeks to incorporate recent evidence, based on a critical review of the literature, to provide practical current recommendations for the prophylactic and therapeutic management of VTE in patients with cancer. Special clinical situations whose management and/or choice of currently recommended therapeutic options (low-molecular-weight heparins [LMWHs] or direct-acting oral anticoagulants [DOACs]) is controversial are included.

Cite

CITATION STYLE

APA

Morán, L. O., Mateo, F. J. P., Balanyà, R. P., Revuelta, J. R., Martínez, S. R., Fombella, J. P. B., … Fernández, M. S. (2024). SEOM clinical guidelines on venous thromboembolism (VTE) and cancer (2023). Clinical and Translational Oncology. https://doi.org/10.1007/s12094-024-03605-2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free